Cybin inc. reports fiscal year 2022 financial results and recent business highlights

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing “psychedelics to therapeuticstm”, today reported audited financial results for its fiscal year ended march 31, 2022 and recent business highlights. the company also reiterated its anticipated pipeline and strategic milestones for the remainder of 2022. “cybin made important progress across the board in recent months, accelerating both our pipeline o
CYBN Ratings Summary
CYBN Quant Ranking